Literature DB >> 11292425

Retinal pigment epithelial tear after photodynamic therapy for choroidal neovascularization.

F Gelisken1, W Inhoffen, M Partsch, U Schneider, I Kreissig.   

Abstract

PURPOSE: To report a case of retinal pigment epithelial tear after photodynamic therapy for choroidal neovascularization.
METHODS: Case report. A 74-year-old woman with exudative age-related macular degeneration and classic subfoveal choroidal neovascularization RE underwent photodynamic therapy with verteporfin.
RESULTS: Ophthalmoscopy and fluorescein angiography RE disclosed a retinal pigment epithelial tear in the area of photodynamic therapy.
CONCLUSION: This case presents the first report of a retinal pigment epithelial tear after photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in age-related macular degeneration.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11292425     DOI： 10.1016/s0002-9394(00)00813-8

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN： 0002-9394            Impact factor:   5.258


  29 in total

Review 1.  [Pigment epithelial detachment in exudative macular degeneration: clinical characteristics and therapeutic options].

Authors:  A Lommatzsch
Journal:  Ophthalmologe       Date:  2010-12       Impact factor: 1.059

2.  Photodynamic therapy with verteporfin for retinal angiomatous proliferation.

Authors:  Francesco Boscia; Maurizio Battaglia Parodi; Claudio Furino; Michele Reibaldi; Carlo Sborgia
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-03-09       Impact factor: 3.117

3.  Retinal pigment epithelial tear following intravitreal ranibizumab injections for neovascular age-related macular degeneration.

Authors:  Gary K Y Lee; Timothy Y Y Lai; Wai-Man Chan; Dennis S C Lam
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-08       Impact factor: 3.117

4.  Retinal pigment epithelial tear after intravitreal ranibizumab for subfoveal CNV secondary to AMD.

Authors:  Rajendra S Apte
Journal:  Int Ophthalmol       Date:  2007-04-06       Impact factor: 2.031

5.  Choroidal folds and retinal pigment epithelium tear following intravitreal bevacizumab injection for exudative age-related macular degeneration.

Authors:  Miwako Kawashima; Ryusaburo Mori; Yoshihiro Mizutani; Mitsuko Yuzawa
Journal:  Jpn J Ophthalmol       Date:  2008-04-30       Impact factor: 2.447

6.  Stimulus-responsive liposomes as smart nanoplatforms for drug delivery applications.

Authors:  Parham Sahandi Zangabad; Soroush Mirkiani; Shayan Shahsavari; Behrad Masoudi; Maryam Masroor; Hamid Hamed; Zahra Jafari; Yasamin Davatgaran Taghipour; Hura Hashemi; Mahdi Karimi; Michael R Hamblin
Journal:  Nanotechnol Rev       Date:  2017-12-12       Impact factor: 7.848

7.  Serous retinal detachment following combined photodynamic therapy and intravitreal bevacizumab injection.

Authors:  Eui Yon Kim; Jong Wan Kim; Jun Bum Kim; Ho Min Lew
Journal:  Korean J Ophthalmol       Date:  2009-06-09

8.  Optical coherence tomographic and visual results at six months after transitioning to aflibercept for patients on prior ranibizumab or bevacizumab treatment for exudative age-related macular degeneration (an American Ophthalmological Society thesis).

Authors:  Clement K Chan; Atul Jain; Srinivas Sadda; Neeta Varshney
Journal:  Trans Am Ophthalmol Soc       Date:  2014-07

9.  Intravitreal aflibercept in treatment-resistant pigment epithelial detachment.

Authors:  Ibrahim Kocak
Journal:  Int Ophthalmol       Date:  2016-07-21       Impact factor: 2.031

10.  Subfoveal hemorrhage after verteporfin photodynamic therapy in treatment of choroidal neovascularization.

Authors:  Faik Gelisken; Werner Inhoffen; Khakima Karim-Zoda; Salvatore Grisanti; Michael Partsch; Michael Voelker; Karl Ulrich Bartz-Schmidt
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-07-17       Impact factor: 3.117
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.